Mitchell F. Brin

A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

C. Warren Olanow, Christopher G. Goetz, Jeffrey H. Kordower et al. · Annals of Neurology · 2003 · 1.6K citations · Full text

Life Sciences, Neurology, Neuroscience +13

The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein

Laurie J. Ozelius, Jeffrey Hewett, Curtis E. Page et al. · Nature Genetics · 1997 · 1K citations

Life Sciences, Genetics, Neuroscience +7

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse et al. · Headache The Journal of Head and Face Pain · 2010 · 986 citations

Medicine, Pharmacology, Pharmacotherapy +17

BOTULINUM TOXIN TYPE A IS A SAFE AND EFFECTIVE TREATMENT FOR NEUROGENIC URINARY INCONTINENCE: RESULTS OF A SINGLE TREATMENT, RANDOMIZED, PLACEBO CONTROLLED 6-MONTH STUDY

Brigitte Schurch, Marianne de Sèze, P. Denys et al. · The Journal of Urology · 2005 · 579 citations

Medicine, Pharmacotherapy, Urology +17

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

Francisco Cruz, Sender Herschorn, Philip J. Aliotta et al. · European Urology · 2011 · 471 citations

Medicine, Pharmacotherapy, Urology +16